Publication:
Three-dimensional-bioprinted liver chips and challenges

Thumbnail Image

School / College / Institute

Organizational Unit

Program

KU Authors

Co-Authors

Özdalgıç, B.
Mustafaoğlu, N.

Publication Date

Language

Embargo Status

NO

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Drug testing, either on animals or on 2D cell cultures, has its limitations due to inaccurate mimicking of human pathophysiology. The liver, as one of the key organs that filters and detoxifies the blood, is susceptible to drug-induced injuries. Integrating 3D bioprinting with microfluidic chips to fabricate organ-on-chip platforms for 3D liver cell cultures with continuous perfusion can offer a more physiologically relevant liver-mimetic platform for screening drugs and studying liver function. The development of organ-on-chip platforms may ultimately contribute to personalized medicine as well as body-on-chip technology that can test drug responses and organ-organ interactions on a single or linked chip model.

Source

Publisher

Multidisciplinary Digital Publishing Institute (MDPI)

Subject

Chemistry, Engineering, Materials science, Physics

Citation

Has Part

Source

Applied Sciences

Book Series Title

Edition

DOI

10.3390/app12105029

item.page.datauri

Link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

0

Views

6

Downloads

View PlumX Details